Ajanta Pharma Limited has informed the Exchange about Transcript
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the exchanges about uploading the written transcript of its earnings call held on 30th April 2025 at 4:30 p.m. The transcript covers the Q4 (Jan-Mar 2024-25) results discussion. It has been filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, and is now available on the company's website. This is a routine compliance filing following the earnings call.
No direct impact on shareholders or stock price as this is simply a procedural disclosure of the earnings call transcript. Investors may want to review the transcript for detailed management commentary on Q4 performance and outlook.